Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | SMARCB1 |
Variant | Q18* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | SMARCB1 Q18* results in a premature truncation of the Smarcb1 protein at amino acid 18 of 385 (UniProt.org). Due to the loss of the MYC-binding and tandem repeat regions (UniProt.org), Q18* is predicted to lead to a loss of Smarcb1 protein function. |
Associated Drug Resistance | |
Category Variants Paths |
SMARCB1 mutant SMARCB1 inact mut SMARCB1 Q18* |
Transcript | NM_003073.5 |
gDNA | chr22:g.23787221C>T |
cDNA | c.52C>T |
Protein | p.Q18* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001007468.2 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001362877.2 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_003073.5 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_003073.4 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001317946.1 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001007468.3 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001317946 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
XM_011530345.2 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_003073 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
XM_011530345 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001317946.2 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
NM_001007468 | chr22:g.23787221C>T | c.52C>T | p.Q18* | RefSeq | GRCh38/hg38 |
Molecular Profile | Protein Effect | Treatment Approaches |
---|---|---|
SMARCB1 Q18* | loss of function - predicted | CDK Inhibitor (Pan) CDK4/6 Inhibitor EZH2 inhibitor Fenretinide MRX34 |